The pathophysiology of portal vein thrombosis in cirrhosis: getting deeper into Virchow's triad

A Anton, G Campreciós, V Pérez-Campuzano… - Journal of Clinical …, 2022 - mdpi.com
Portal vein thrombosis (PVT) is a common complication among patients with cirrhosis.
However, its pathophysiology is not well established and there are currently very few …

[HTML][HTML] Effect of portal vein thrombosis on the prognosis of patients with cirrhosis without a liver transplant: a systematic review and meta-analysis

J Xian, Y Tang, H Shao, X Wang, M Zhang, T Xing - Medicine, 2021 - journals.lww.com
Background: Portal vein thrombosis (PVT) is a relatively common complication of cirrhosis.
However, the effect of PVT on the prognosis might not be unequivocal. A systematic review …

A practical nomogram based on systemic inflammatory markers for predicting portal vein thrombosis in patients with liver cirrhosis

Y Xing, Z Tian, Y Jiang, G Guan, Q Niu, X Sun… - Annals of …, 2022 - Taylor & Francis
Introduction Immunothrombosis has recently been used to describe the responses/
mechanisms in thrombosis. Systemic inflammatory markers are prognostic markers for a …

Evaluation of coagulation, fibrinolysis and endothelial biomarkers in cirrhotic patients with or without portal venous thrombosis

W Ren, J Zhang, Y Chen, M Wen, Y Su… - Clinical and Applied …, 2020 - journals.sagepub.com
To evaluate variations in coagulation, fibrinolysis and endothelial marker expression in
cirrhotic patients and to explore their clinical value and predictive performance in cirrhotic …

Portal vein thrombosis in cirrhosis: Interventional treatment options

C Molvar, P Amin - Current Gastroenterology Reports, 2021 - Springer
Abstract Purpose of Review Portal vein thrombosis (PVT) is a frequent consequence of
cirrhosis and its management is variable and controversial. Herein we highlight …

AngioJet aspiration thrombectomy combined with transcatheter thrombolysis in treatment of acute portal venous systemic thrombosis

G Cai, C Li, Z Hua, P Xu, Z Jiao, H Cao, S Liu… - Annals of Vascular …, 2020 - Elsevier
Background This study set out to assess the feasibility, effectiveness, and safety of
percutaneous AngioJet aspiration thrombectomy combined with transcatheter thrombolysis …

Research progress in Chinese medicine preparations for promoting blood circulation and removing blood stasis for cirrhotic patients with portal vein thrombosis …

D Zhang, Y Mu, Y Xu, J Chen, P Liu, W Liu - Chinese Journal of Integrative …, 2022 - Springer
This article presented an overview of the therapeutic effects of Chinese medicine (CM)
preparations for promoting blood circulation and removing blood stasis for patients with …

Increased Factor VIII Activity Is Predictive of the Occurrence of Portal Vein Thrombosis in Cirrhosis

S Jiang, Y Ai, X Fan, X Huang, L Wu… - Thrombosis and …, 2023 - thieme-connect.com
Background The aim of this study was to identify the role of factor VIII (FVIII) in portal vein
thrombosis (PVT) occurrence in cirrhotic patients with gastroesophageal variceal bleeding …

[HTML][HTML] Risk factors, clinical presentation, diagnosis, and treatment outcomes of portal vein thrombosis: A five-year hospital-based study from Qatar

FY Khan, E Habas, TO Sulaiman… - Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
Background There is a lack of robust epidemiological information on portal vein thrombosis
(PVT) in Qatar. This study aimed to describe the risk factors, clinical presentation, diagnosis …

[HTML][HTML] 新型口服抗凝药在肝硬化合并门静脉血栓的治疗进展

周好男, 陈以宽 - Advances in Clinical Medicine, 2023 - hanspub.org
门静脉血栓(PVT) 是肝硬化患者的常见并发症, 可合并腹水, 凝血功能异常, 静脉曲张出血等.
目前抗凝治疗作为一线治疗. 与传统抗凝药相比, 新型口服抗凝药具有起效快, 不需要常规监测 …